Clinical efficacy and safety assessment of high-dose Bevacizumab plus Fluorouracil and Leucovorin (sLV5FU2) in patients with standard chemotherapy refractory metastatic colorectal cancer. phase II multicenter trial.
收藏NIAID Data Ecosystem2026-03-07 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2625196
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: High-dose Bevacizumab + sLV5FU2 Bevacizumab 10mg/kg (d.i.v) l-LV 200mg/m2 (d.i.v) 5-FU 400mg/m2 (b.i.v) 5-FU 2400mg/m2 (c.i.v) Every 2weeks
Primary outcome(s): Progression-free survival
Study Design: Single arm Non-randomized
创建时间：
2013-01-15
